Skip to content

Clinical trials

Completed Phase 3 Lymphoproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Phase: Phase 3 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20051
20061
20084
20101
20151
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology3
Amgen1
Case Comprehensive Cancer Center1
Jonsson Comprehensive Cancer Center1
Mayo Clinic1
Merck Sharp & Dohme LLC1
Radiation Therapy Oncology Group1
University of Edinburgh1
University of Heidelberg Medical Center1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders14
Multiple Myeloma9
Lymphoma8
Neoplasms, Plasma Cell8
Leukemia7
Hodgkin Disease6
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, Follicular6
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Large-Cell, Anaplastic6

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.